Search

everythinglearnresearchcommunity

for

Search:↓

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Doctors should prescribe cheaper, off-label medication and teach patients how to use it to save money ethically.

PRP combined with Ayurvedic medicine may effectively treat hair loss.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

Independent pharmacies generally offer lower prices for certain generic urologic medications than chain pharmacies.

Switching to generic tacrolimus was safe, effective, and saved money.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Some generic finasteride may be counterfeit, leading to less effectiveness and increased hair loss.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

New tests detect finasteride and dutasteride in urine quickly and easily.

The document concludes that a Quality Management System is crucial for maintaining product quality through innovation and proper technology transfer in the pharmaceutical industry.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Procyanidins may have antioxidant, heart health, cancer-fighting, anti-inflammatory, anti-diabetic, liver-protective, and other health benefits with high efficiency and low toxicity.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Skin treatment can lower life quality for patients with skin conditions.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Most UK dental schools don't teach non-surgical facial aesthetics, but dentists have a good knowledge base to provide these services.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.